Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response

Journal of the Formosan Medical Association

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2joQeqe
via IFTTT